Genfit S.A. Announces Shareholder Meeting Date
| Field | Detail |
|---|---|
| Company | Genfit S.A. |
| Form Type | 6-K |
| Filed Date | May 7, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: shareholder-meeting, corporate-governance
TL;DR
Genfit's shareholder meeting is set for June 17, 2025. Check their site for details.
AI Summary
Genfit S.A. announced its Combined Shareholders' Meeting will be held on June 17, 2025, at 10 a.m. CEST in Lille, France. Shareholders can find additional information on the company's website in the Investors & Media section.
Why It Matters
This meeting is crucial for shareholders to vote on company matters and understand Genfit's strategic direction.
Risk Assessment
Risk Level: low — This filing is a routine announcement of a shareholder meeting and does not contain new financial or operational risks.
Key Players & Entities
- Genfit S.A. (company) — Registrant
- June 17, 2025 (date) — Shareholders' Meeting date
- 10 a.m. CEST (time) — Shareholders' Meeting time
- Lille, France (location) — Shareholders' Meeting location
FAQ
When and where will Genfit S.A.'s Combined Shareholders' Meeting take place?
The meeting will be held on June 17, 2025, beginning at 10 a.m. CEST at the Faculté de Pharmacie de Lille located at Parc Eurasanté, 3 rue du Professeur Laguesse in Lille (59000), France.
What is the purpose of this filing?
This is a Form 6-K report of a foreign private issuer, announcing the date and location of Genfit S.A.'s Combined Shareholders' Meeting.
Where can shareholders find more information about the meeting?
Additional information regarding the Meeting is available to shareholders on the Company's website, in the Investors & Media section.
Does Genfit S.A. file annual reports under Form 20-F or 40-F?
Genfit S.A. files annual reports under cover of Form 20-F.
What is Genfit S.A.'s primary business?
Genfit S.A. is in the business of Biological Products (No Diagnostic Substances).
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on May 7, 2025 regarding Genfit S.A..